Leptin signal transduction in the HP75 human pituitary cell line

Pituitary

Volumn 3, Issue 4, 2000, Pages 211-220

  Tsumanuma, Itaru ^a   Jin, AuLong ^a   Zhang, Shuya ^a   Bayliss, Jill M ^a   Scheithauer, Bernd W ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

Author keywords

HP75 cells; Pituitary; STATs and SOCS 3

Indexed keywords

CYTOKINE; LEPTIN; MESSENGER RNA;

ADENOHYPOPHYSIS; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPOPHYSIS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ADENOMA; ANTIGENS, POLYOMAVIRUS TRANSFORMING; APOPTOSIS; CARRIER PROTEINS; CELL CYCLE PROTEINS; CELL DIVISION; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; CYCLINS; DNA-BINDING PROTEINS; GENE EXPRESSION; HUMANS; LEPTIN; MILK PROTEINS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PHOSPHOTYROSINE; PITUITARY GLAND; PITUITARY NEOPLASMS; PROTEINS; RECEPTORS, CELL SURFACE; RECOMBINANT PROTEINS; REPRESSOR PROTEINS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 0034578568     PISSN: 1386341X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012994712851     Document Type: Article

References (58)

1. Positional cloning of the mouse obese gene and its human homologue
2. Leptin sensitive neurons in the hypothalamus
3. Effects of the obese gene product on body weight regulation in ob/ob mice
4. Leptin expression in human mammary epithelial cells and breast milk
5. Synthesis of leptin in human placenta
6. Nonadipose tissue production of leptin: Leptin as a novel placenta-derived derived hormone in humans
7. Leptin gene expression in the brain and pituitary gland
8. Leptin and leptin receptor expression in normal and neoplastic human pituitary: Evidence of a regulatory role for leptin on pituitary cell proliferation
9. Identification and expression cloning of a leptin receptor; ob-r
10. Identification of targets of leptin action in rat hypothalamus
11. Abnormal splicing of the leptin receptor in diabetic mice
12. Evidence that the diabetes gene encodes the leptin receptor: Identification of a mutation in the leptin receptor gene in db/db mice
13. Divergent signaling capacities of the long and short isoforms of the leptin receptor
14. Leptin induces mitogen-activated protein kinase-dependent proliferation of c3h10t1/2 cells
15. Overlapping and distinct signals through leptin receptor (ob-r) and a closely related cytokine signal transducer, gp130
16. Activation of downstream signals by the long form of the leptin receptor
17. The leptin receptor activates janus kinase 2 and signals for proliferation in a factor-dependent cell line
18. Leptin activation of stat3 in the hypothalamus of wild-type and ob/ob mice but not db/db mice
19. The full-length leptin receptor has signaling capabilities of interleukin 6-type cytokine receptors
20. Defective stat signaling by the leptin receptor in diabetic mice
21. Jak-stat pathways and transcriptional activation in response to ifns and other extracellular signaling proteins
22. Interleukin-6-type cytokine signalling through the gp130/jak/stat pathway
23. Intact leptin receptor is selectively expressed in human fetal pituitary and pituitary adenomas and signals human fetal pituitary growth hormone secretion
24. Leptin stimulates basal and ghrh-induced gh release from cultured rat anterior pituitary cells in vitro
25. Role of leptin in hypothalamic-pituitary function
26. Leptin regulates prothyrotropin-releasing hormone (protrh) biosynthesis: Evidence for direct and indirect pathways
27. Nitric oxide mediates leptin-induced luteinizing hormone-releasing hormone (lhrh) and lhrh and leptin-induced lh release from the pituitary gland
28. A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
29. Expression and localization of the leptin receptor in endocrine and neuroendocrine tissues of the rat
30. Upregulation of leptin receptor gene expression in the anterior pituitary of human growth hormone-releasing hormone transgenic mice
31. Expression of leptin receptor mRNA and the long form splice variant in human anterior pituitary and pituitary adenoma
32. Long form leptin receptor mRNA expression in the brain, pituitary, and other tissues in the pig
33. Establishment of a folliculo-stellate-like cell line from a murine thyrotropic pituitary tumor
34. Pituitary corticotroph socs-3: Novel intracellular regulation of leukemia-inhibitory factor-mediated proopiomelanocortin gene expression and adrenocorticotropin secretion
35. Autoregulation of pituitary corticotroph socs-3 expression: Characterization of the murine socs-3 promoter
36. Inhibitory roles for shp-1 and socs-3 following pituitary proopiomelanocortin induction by leukemia inhibitory factor
37. A human pituitary adenoma cell line proliferates and maintain some differential functions following expression of sv40 large t-antigen
38. 3h]thymidine uptake in htc-4 and llc-11 tumor cells
39. Socs-3 is tyrosine phosphorylated in response to interleukin-2 and suppresses stat5 phosphorylation and lymphocyte proliferation
40. Leukemia inhibitory factor (lif) stimulates proopiomelanocortin (pomc) expression in a corticotroph cell line. Role of stat pathway
41. Leukemia inhibitory factor regulates proopiomelanocortin transcription
42. The inhibition of interleukin-6-dependent stat activation by mitogen-activated protein kinases depends on tyrosine 759 in the cytoplasmic tail of glycoprotein 130
43. Constitutive stat3, tyr705, and ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6
44. Constitutive activation of stat3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells
45. Identification and characterization of a constitutively active stat5 mutant that promotes cell proliferation
46. Stat3 as an oncogene
47. Stat5 is a physiological substrate of the insulin receptor
48. Stat3 activation is responsible for il-6-dependent t cell proliferation through preventing apoptosis: Generation and characterization of the cell-specific stat3-deficient mice
49. Stat5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells
50. Stats in oncogenesis
51. Role of suppressors of cytokine signaling (socs) in leukemia inhibitory factor (lif)-dependent embryonic stem cell survival
52. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 waf1/cip1 mediated by stat1
53. Transcriptional activation of the p21(waf1, cip1, sdi1) gene by interleukin-6 type cytokines. A prerequisite for their prodifferentiating and anti-apoptotic effects on human osteoblastic cells
54. Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, cmk, involves transcriptional activation of p21(waf1/cip1) by stat5
55. Interleukin-6 and oncostatin m-induced growth inhibition of human a375 melanoma cells is stat-dependent and involves upregulation of the cyclin-dependent kinase inhibitor p27/kip1
56. Apoptosis in nontumorous and neoplastic human pituitaries: Expression of the bcl-2 family of proteins
57. Pituitary adenylate cyclase-activating polypeptide inhibits transforming growth factor-beta1-induced apoptosis in a human pituitary adenoma cell line
58. Mitogen-activated protein kinase pathways